Viewing Study NCT04384692


Ignite Creation Date: 2025-12-24 @ 3:15 PM
Ignite Modification Date: 2026-02-23 @ 6:27 AM
Study NCT ID: NCT04384692
Status: RECRUITING
Last Update Posted: 2025-09-05
First Post: 2020-05-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Peritransplant Ruxolitinib for Patients With Primary and Secondary Myelofibrosis
Sponsor: Fred Hutchinson Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Primary Myelofibrosis View
None Secondary Myelofibrosis View
Keywords: